Clinical Trial Update: Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer [Phase 2]

View source ↗

Summary

Update on a Phase 2 neoadjuvant trial of nab-paclitaxel plus carboplatin in breast cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: Shanghai Cancer Hospital, China | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN